Publication: Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells
Issued Date
2012-08-01
Resource Type
ISSN
18734847
09552863
09552863
Other identifier(s)
2-s2.0-84863992249
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Nutritional Biochemistry. Vol.23, No.8 (2012), 915-923
Suggested Citation
Thararat Nualsanit, Pleumchitt Rojanapanthu, Wandee Gritsanapan, Seong Ho Lee, Darunee Lawson, Seung Joon Baek Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells. Journal of Nutritional Biochemistry. Vol.23, No.8 (2012), 915-923. doi:10.1016/j.jnutbio.2011.04.017 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/13648
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells
Other Contributor(s)
Abstract
Damnacanthal, an anthraquinone compound, is isolated from the roots of Morinda citrifolia L. (noni), which has been used for traditional therapy in several chronic diseases including cancer. Although noni has been consumed for a long time in Asian and Polynesian countries, the molecular mechanisms by which it exerts several benefits are starting to emerge. In this report, we examined systematic approaches on the cancer-suppressing capability of damnacanthal in colorectal tumorigenesis. Damnacanthal exhibits cell growth arrest as well as caspase activity induction in colorectal cancer cells. We also examined several potential target proteins and found that the proapoptotic protein nonsteroidal anti-inflammatory activated gene-1 (NAG-1) is highly induced. Subsequently, we have found that damnacanthal also enhances transcription factor CCAAT/enhancer binding protein β (C/EBPβ), which controls NAG-1 transcriptional activity. Blocking of C/EBPβ by shRNA results in the reduction of NAG-1 expression as well as caspase activity in the presence of damnacanthal. Taken together, these results indicate that damnacanthal increases antitumorigenic activity in human colorectal cancer cells and that C/EBPβ plays a role in damnacanthal-induced NAG-1 expression. © 2012 Elsevier Inc.